LivaNova LIVN
NASDAQ LIVN
$78.96 -1.74 (-2.16%)
As of: Sep 9, 2026 · 3:59 PM EDT

LivaNova (LIVN) Cash from Investing Activities (2015 - 2026)

LivaNova's (LIVN) quarterly Cash from Investing Activities came in at -$31.9 million in Q2 2026, down 255.9% year-over-year from $20.5 million in Q2 2025, and down 118.91% quarter-over-quarter from -$14.6 million in Q1 2026.

Analysis

LivaNova (LIVN) Cash from Investing Activities (2015 - 2026) Analysis & Trends

LivaNova has disclosed Cash from Investing Activities across 12 years of filings, most recently posting -$31.9 million for Q2 2026.

  • In Q2 2026, Cash from Investing Activities fell 255.9% year-over-year to -$31.9 million; the TTM figure through Jun 2026 stood at -$99.8 million (down 104.43% YoY), while the FY2025 annual figure was -$72.9 million, down 51.4% from the prior year.
  • Cash from Investing Activities came in at -$31.9 million for Q2 2026 at LivaNova, down from -$14.6 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of -$5.5 million in Q1 2022 to a low of -$31.9 million in Q2 2026.
  • Average Cash from Investing Activities over 5 years is -$13.7 million, with a median of -$11.2 million recorded in 2022.
  • Year-over-year, Cash from Investing Activities surged 58.79% in 2023 and plunged 255.9% in 2026.
  • Over 5 years, Cash from Investing Activities stood at -$11.0 million in 2022, then retreated by 10.82% to -$12.1 million in 2023, then rose by 11.78% to -$10.7 million in 2024, then plunged by 182.58% to -$30.3 million in 2025, then declined by 5.48% to -$31.9 million in 2026.
  • Per Business Quant data, the three most recent Cash from Investing Activities figures were -$31.9 million in Q2 2026, -$14.6 million in Q1 2026, and -$30.3 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn -673.00 Mn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn -26.60 Mn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn -1.62 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn -639.00 Mn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn -1.96 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn -193.20 Mn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn -222.00 Mn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 329.80 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn -108.50 Mn
10 LivaNova 4.34 Bn 3.82 Bn 273.67 Mn -31.92 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -31.92 Mn
Mar 31, 2026 -14.58 Mn
Dec 31, 2025 -30.26 Mn
Sep 30, 2025 -23.06 Mn
Jun 30, 2025 -8.97 Mn
Mar 31, 2025 -10.63 Mn
Dec 31, 2024 -10.71 Mn
Sep 30, 2024 -18.52 Mn
Jun 30, 2024 -12.57 Mn
Mar 31, 2024 -6.36 Mn
Dec 31, 2023 -12.14 Mn
Sep 30, 2023 -10.05 Mn
Jun 30, 2023 -6.66 Mn
Mar 31, 2023 -11.48 Mn
Dec 31, 2022 -10.95 Mn
Sep 30, 2022 -5.83 Mn
Jun 30, 2022 -16.15 Mn
Mar 31, 2022 -5.48 Mn
Dec 31, 2021 -3.63 Mn
Sep 30, 2021 -6.18 Mn